Inflammatory Response After Muscle and Skeleton Trauma
IRAMST
Inflammatory Response in Polytraumatized Patients
1 other identifier
observational
48
1 country
1
Brief Summary
The purpose of this study is to determine the inflammatory response after multiple trauma in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2008
CompletedFirst Posted
Study publicly available on registry
July 4, 2008
CompletedStudy Start
First participant enrolled
April 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 17, 2015
December 1, 2015
6.5 years
July 2, 2008
December 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inflammatory pattern of complement activation, biomarkers and complement-regulating proteins (CRegs)on leukocytes
0, 1, 4, 12, 24, 48, 96, 120 und 240 h after trauma
Secondary Outcomes (1)
inflammatory biomarkers, cell surface markers, apoptosis, functional polymorphisms, mesenchymal stem cells, severity of injury (ISS), infections, SIRS, sepsis, shock, organ dysfunctions, severity of disease, ICU length of stay, wound healing, mortality
0, 1, 4, 12, 24, 48, 96, 120 und 240 h after trauma for biochemical and immunological parameters; ISS on admission; scores on a daily basis; ICU and hospital death on discharge
Study Arms (1)
A, 2
Polytraumatized patients with ISS \> 18 and healthy controls
Eligibility Criteria
Polytraumatized patients with an ISS \> 18 Controls: healthy volunteers
You may qualify if:
- multiple trauma injury, injury severity score (ISS) \> 18 with
- isolated fractures of the extremities
- fractures of the extremities combined with blunt/penetrating visceral trauma
- fractures of the extremities combined with blunt/penetrating thoracic trauma
- isolated head injury with morphological changes in CCT
- combination of points 1 - 4
You may not qualify if:
- life expectancy \< 24 hours
- participation in other trials
- ISS \< 18
- cardiopulmonary reanimation on the accident scene or dying immediately after hospital admission
- age \< 18 years
- known or suspected pregnancy
- patients with ray-treatment or chemotherapy within the last three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Ulmlead
- German Research Foundationcollaborator
Study Sites (1)
Clinic of Anesthesiology and Clinic of Traumatology, Hand-, Plastic-, and Reconstructive Surgery
Ulm, 89070, Germany
Related Publications (4)
Huber-Lang M, Denk S, Fulda S, Erler E, Kalbitz M, Weckbach S, Schneider EM, Weiss M, Kanse SM, Perl M. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro. Mol Immunol. 2012 Feb;50(1-2):60-5. doi: 10.1016/j.molimm.2011.12.005. Epub 2012 Jan 14.
PMID: 22244896RESULTUnnewehr H, Rittirsch D, Sarma JV, Zetoune F, Flierl MA, Perl M, Denk S, Weiss M, Schneider ME, Monk PN, Neff T, Mihlan M, Barth H, Gebhard F, Ward PA, Huber-Lang M. Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol. 2013 Apr 15;190(8):4215-25. doi: 10.4049/jimmunol.1200534. Epub 2013 Mar 11.
PMID: 23479227RESULTDenk S, Wiegner R, Hones FM, Messerer DA, Radermacher P, Weiss M, Kalbitz M, Ehrnthaller C, Braumuller S, McCook O, Gebhard F, Weckbach S, Huber-Lang M. Early Detection of Junctional Adhesion Molecule-1 (JAM-1) in the Circulation after Experimental and Clinical Polytrauma. Mediators Inflamm. 2015;2015:463950. doi: 10.1155/2015/463950. Epub 2015 Oct 18.
PMID: 26556956RESULTKozarcanin H, Lood C, Munthe-Fog L, Sandholm K, Hamad OA, Bengtsson AA, Skjoedt MO, Huber-Lang M, Garred P, Ekdahl KN, Nilsson B. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation. J Thromb Haemost. 2016 Mar;14(3):531-45. doi: 10.1111/jth.13208. Epub 2016 Feb 15.
PMID: 26614707RESULT
Biospecimen
Whole blood, serum, white cells, and tissues will be retained.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manfred M Weiss, MD, MBA
Clinic of Anesthesiology, University Hospital Medical School, Steinhoevelstrasse 9, 89070 Ulm, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MD, MBA
Study Record Dates
First Submitted
July 2, 2008
First Posted
July 4, 2008
Study Start
April 1, 2009
Primary Completion
October 1, 2015
Study Completion
December 1, 2015
Last Updated
December 17, 2015
Record last verified: 2015-12